Author:
Bech P.,Cialdella P.,Haugh M. C.,Birkett M. A.,Hours A.,Boissel J. P.,Tollefson G. D.
Abstract
BackgroundPrevious meta-analyses of fluoxetine as an antidepressant have many methodological problems, including diagnosis of major depression, validity of outcome measures and lack of intention-to-treat analyses.AimsTo provide an estimate of the effect of fluoxetine compared with placebo and tricyclic antidepressants (TCAs), and to investigate reasons for early discontinuation from acute treatment.MethodRandomised trials were analysed using both intention-to-treat, efficacy and end-point.ResultsFluoxetine was superior to placebo but effect size was low. In trials comparing fluoxetine v. TCA, the results for all trials and for the USA trials showed a trend in favour of fluoxetine. Those for the non-USA trials showed a trend in favour of TCA. When combined, the results showed that significantly fewer patients on fluoxetine discontinued treatment because of adverse events.ConclusionFluoxetine is superior to placebo, irrespective of the analytical approach use, whereas the results obtained v. TCAs depend on the approach used. Hence, the results should be interpreted in this light.
Publisher
Royal College of Psychiatrists
Subject
Psychiatry and Mental health
Reference26 articles.
1. A general parametric approach to the meta-analysis of randomized clinical trials
2. Smith A. , Traganza E. & Harrison G. (1969) Studies on the effectiveness of antidepressant drugs. Psychopharmacology Bulletin, suppl., 1–53.
3. Sensitivity of the six-item Hamilton Depression Rating Scale
4. Meta-analysis in clinical trials;Laird;Controlled Clinical Trials,1986
Cited by
141 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献